205 related articles for article (PubMed ID: 3510799)
21. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
[TBL] [Abstract][Full Text] [Related]
22. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
Chang AC; Atz AM; Wernovsky G; Burke RP; Wessel DL
Crit Care Med; 1995 Nov; 23(11):1907-14. PubMed ID: 7587268
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W
N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453
[TBL] [Abstract][Full Text] [Related]
24. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
Monrad ES; McKay RG; Baim DS; Colucci WS; Fifer MA; Heller GV; Royal HD; Grossman W
Circulation; 1984 Dec; 70(6):1030-7. PubMed ID: 6499142
[TBL] [Abstract][Full Text] [Related]
25. [Additive effects of milrinone and dobutamine in severe heart failure].
Meissner A; Herrmann G; Gerdesmeyer L; Simon R
Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
[TBL] [Abstract][Full Text] [Related]
26. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
Townend JN; Doran J; Lote CJ; Davies MK
Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic and regional blood flow response to milrinone in patients with severe congestive heart failure: a dose-ranging study.
Fitzpatrick PG; Cinquegrani MP; Vakiener AR; Baggs JG; Biddle TL; Liang CS; Hood WB
Am Heart J; 1987 Jul; 114(1 Pt 1):97-105. PubMed ID: 3604878
[TBL] [Abstract][Full Text] [Related]
28. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.
Simonton CA; Chatterjee K; Cody RJ; Kubo SH; Leonard D; Daly P; Rutman H
J Am Coll Cardiol; 1985 Aug; 6(2):453-9. PubMed ID: 4019930
[TBL] [Abstract][Full Text] [Related]
29. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
30. Acute dose range study of milrinone in congestive heart failure.
Kubo SH; Cody RJ; Chatterjee K; Simonton C; Rutman H; Leonard D
Am J Cardiol; 1985 Mar; 55(6):726-30. PubMed ID: 3976517
[TBL] [Abstract][Full Text] [Related]
31. Effects of variable dose milrinone in patients with low cardiac output after cardiac surgery. European Multicenter Trial Group.
Feneck RO
Am Heart J; 1991 Jun; 121(6 Pt 2):1995-9. PubMed ID: 2035429
[TBL] [Abstract][Full Text] [Related]
32. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.
Grose R; Strain J; Greenberg M; LeJemtel TH
J Am Coll Cardiol; 1986 May; 7(5):1107-13. PubMed ID: 3958369
[TBL] [Abstract][Full Text] [Related]
33. Milrinone in heart failure. Effects on exercise haemodynamics during short term treatment.
Timmis AD; Smyth P; Jewitt DE
Br Heart J; 1985 Jul; 54(1):42-7. PubMed ID: 4015915
[TBL] [Abstract][Full Text] [Related]
34. Effects of milrinone on hemodynamics and regional blood flow in the hypoxic dog.
Setoyama K; Ota H; Miura N; Fujiki M; Misumi K; Sakamoto H
J Vet Med Sci; 2002 Jun; 64(6):499-503. PubMed ID: 12130834
[TBL] [Abstract][Full Text] [Related]
35. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS
Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
[TBL] [Abstract][Full Text] [Related]
36. Central and regional vascular hemodynamics following intravenous milrinone in the conscious rat: comparison with dobutamine.
Drexler H; Höing S; Faude F; Wollschläger H; Just H
J Cardiovasc Pharmacol; 1987 May; 9(5):563-9. PubMed ID: 2439838
[TBL] [Abstract][Full Text] [Related]
37. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
Monrad ES; Baim DS; Smith HS; Lanoue AS
Circulation; 1986 Mar; 73(3 Pt 2):III168-74. PubMed ID: 3510773
[TBL] [Abstract][Full Text] [Related]
38. Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease.
Sinoway LS; Maskin CS; Chadwick B; Forman R; Sonnenblick EH; Le Jemtel TH
J Am Coll Cardiol; 1983 Aug; 2(2):327-31. PubMed ID: 6863765
[TBL] [Abstract][Full Text] [Related]
39. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
[TBL] [Abstract][Full Text] [Related]
40. Short-term assessment of left ventricular function, coronary hemodynamics, and catecholamine balance in severe congestive heart failure after a single oral dose of milrinone.
Piscione F; Jaski BE; Serruys PW
J Cardiovasc Pharmacol; 1988 Mar; 11(3):258-69. PubMed ID: 2452918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
